[Clinical use of sodium hypochlorite for local treatment and prevention of urinary tract infections and therapy of contracted bladders (author's transl)].
A stable commercial electrolytic sodium hypochlorite solution was tested in 63 urologic patients. The complete germicidal action against all sorts of bacteria was shown in suspension-tests. Irrigation studies of the infected bladder were performed. It was found that continued bladder irrigations were necessary to stop bacterial ascension from the infected urethra. Bladder capacity was increased in 6 of 8 patients with nonmalignant contracted bladder or interstitial cystitis. Desinfection with sodium hypochlorite in urologic practice is cheap, easy to perform and diminishes the risk of hospitalism. Clinical studies confirmed the absence of general or local toxicity.
D000143:Acids / Q000627:therapeutic use*; D003428:Cross Infection / Q000517:prevention & control; D003556:Cystitis / Q000188:drug therapy; D005260:Female; D006801:Humans; D006997:Hypochlorous Acid / Q000009:adverse effects / Q000627:therapeutic use*; D007710:Klebsiella Infections / Q000188:drug therapy; D008297:Male; D011512:Proteus Infections / Q000188:drug therapy; D011552:Pseudomonas Infections / Q000188:drug therapy; D011550:Pseudomonas aeruginosa; D013530:Surgical Wound Infection / Q000517:prevention & control; D007507:Therapeutic Irrigation; D014526:Urethritis / Q000188:drug therapy; D001745:Urinary Bladder Diseases / Q000188:drug therapy*; D014546:Urinary Catheterization; D014552:Urinary Tract Infections / Q000188:drug therapy* / Q000517:prevention & control
D000143:Acids; D006997:Hypochlorous Acid
Die klinische Anwendung von NaOC1 zur lokalen Behandlung und Prophylaxe von Harnwegsinfekten und Therapie von Schrumpfblasen